EyePoint Pharmaceuticals
EYPT
#6156
Rank
A$1.59 B
Marketcap
A$18.48
Share price
-0.15%
Change (1 day)
17.41%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -A$0.41 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$7.61 Million. In 2025 the company made an earning of -A$0.33 Billion a decrease over its 2024 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.41 Billion22.49%
2025 -A$0.33 Billion63.24%
2024 -A$0.21 Billion104.29%
2023 -A$98.4 Million-29.88%
2022 -A$0.15 Billion87.2%
2021 -A$74.96 Million38.58%
2020 -A$54.09 Million-24.56%
2019 -A$71.7 Million
2017 -A$32.71 Million22.59%
2016 -A$26.68 Million-8.02%
2015 -A$29 Million-296.09%
2014 A$14.78 M-174.02%
2013 -A$19.98 Million37.42%
2012 -A$14.54 Million-56.29%
2011 -A$33.26 Million-1062.38%
2010 A$3.45 M-250.43%
2009 -A$2.3 Million-89.5%
2008 -A$21.89 Million
2005 -A$13.5 Million56.99%
2004 -A$8.6 Million73.7%
2003 -A$4.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.07 Million-99.20% Bahamas
NRC Health
NRC
A$27.78 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA